Atlantic Union Bankshares’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198K Sell
935
-2
-0.2% -$393 ﹤0.01% 627
2026
Q1
$184K Buy
937
+2
+0.2% +$389 ﹤0.01% 602
2025
Q4
$162K Sell
935
-15
-2% -$2.73K ﹤0.01% 628
2025
Q3
$181K Buy
950
+500
+111% +$88.7K ﹤0.01% 617
2025
Q2
$80.8K Buy
+450
New +$78.2K ﹤0.01% 588

Other funds holding DGX

Atlantic Union Bankshares's DGX Position: Q2 2026 in Review

Atlantic Union Bankshares reduced its Quest Diagnostics (DGX) stake by 0.21% in Q2 2026, selling an estimated $393 and leaving 935 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

Atlantic Union Bankshares first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Atlantic Union Bankshares held 935 shares of Quest Diagnostics worth $198K as of Q2 2026.
  • Atlantic Union Bankshares sold 2 Quest Diagnostics shares in Q2 2026, an estimated $393.
  • Quest Diagnostics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #627 holding.
  • Atlantic Union Bankshares first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.